Azelastine is a selective histamine H1-receptor antagonist primarily indicated for the treatment of allergic rhinitis and conjunctivitis. This category provides a comprehensive selection of pharmaceutical… Read more
![Chemical structure of (R)-4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1-oxido-1H-azepin-4-yl)-1(2H)-phthalazinone;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346617-18-2-R-4-4-Chlorophenylmethyl-2-hexahydro-1-methyl-1-oxido-1H-azepin-4-yl-12H-phthalazinone.png&w=3840&q=75)















































Azelastine is a selective histamine H1-receptor antagonist primarily indicated for the treatment of allergic rhinitis and conjunctivitis. This category provides a comprehensive selection of pharmaceutical reference standards for Azelastine, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories engaged in rigorous analytical testing, impurity profiling, and quality control. By using these standards, researchers can effectively perform method validation, stability studies, and quantitative analysis, ensuring compliance with international regulatory guidelines. Stable isotope labelled analogues serve as critical internal standards for mass spectrometry-based assays, providing the precision required to accurately monitor degradation products and process-related impurities. Whether conducting routine batch release testing or complex method development, these reference materials support the accuracy and reliability of analytical procedures across the drug development lifecycle.